| Followers | 686 |
| Posts | 142475 |
| Boards Moderated | 35 |
| Alias Born | 03/10/2004 |
Thursday, June 24, 2021 2:11:56 PM
By: MarketBeat | June 22, 2021
CVS Health (NYSE:CVS) had its price objective reduced by analysts at Deutsche Bank Aktiengesellschaft from $99.00 to $95.00 in a research report issued on Tuesday, The Fly reports. The firm currently has a "buy" rating on the pharmacy operator's stock. Deutsche Bank Aktiengesellschaft's price objective would suggest a potential upside of 13.07% from the stock's previous close...
Read Full Story »»»
DiscoverGold
Information posted to this board is not meant to suggest any specific action, but to point out the technical signs that can help our readers make their own specific decisions. Caveat emptor!
• DiscoverGold
Recent CVS News
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
